Specialty Areas: Lung Transplant and Pulmonary hypertension
Chronology: BS and BA: University of California Davis 2005; DO: A.T. Still University, Kirksville College of Osteopathic Medicine, 2011; Internal Medicine Residency: Indiana University 2011-2014; Pulmonary and Critical Care Fellowship: Indiana University 2014-2017; Lung Transplant and Pulmonary Hypertension Fellowship: Indiana University 2017-2018; Assistant Professor of Clinical Medicine: University of North Carolina 2018 to present.
Dr. Krishnan is interested in the pulmonary vascular changes that occur in advanced lung disease, particularly as they relate to worsening chronic hypoxia.
2018 Krishnan S, Kniese CM, Mankins M, Heitkamp DE, Sheski FD, Kesler KA. Management of Broncholithiasis. Journal of Thoracic Disease2018 Oct 2018.
2018 Krishnan S, Lahm T. A Case Report of Hepatopulmonary Syndrome in Hereditary Hemorrhagic Telangiectasia (HHT): Not all Right-to-Left Shunting in HHT is Due to Pulmonary Ateriovenous Malformations. MedicineAug 2018.
2017 Mizumura K, Justice M, Schweitzer K, Krishnan S, Bronova I, Berdyshev E, Hubbard W, Pewzner-Jung Y, Futerman A, Choi A, Petrache I. Sphingolipid regulation of lung epithelial cell mitophagy and necroptosis during cigarette smoke exposure. Federation of American Societies for Experimental Biology Journal. Dec 2017.
2007 Franz CE, Barker JC, Kravitz RL, Flores Y, Krishnan S, Hinton L. Non-medical influences on the use of cholinesterase inhibitors in dementia care. Alzheimer Disease & Associated Disorders; Jul/Sept: 21:241-248.